Since the atomic bomb explosions in Hiroshima and Nagasaki, high incidences
of leukemia, thyroid cancer and other tumors have been reported as atomic
bomb-induced tumors. We investigated the incidence of meningioma among Hiro
shima atomic bomb survivors. Sixty-eight patients surgically treated for me
ningioma who had been within 2.0 km of the hypocenter of the explosion were
identified. Six hundred and seven non-exposed patients with meningioma wer
e also studied. Treatment dates were from 1975 to 1992. The incidences of m
eningioma among 68 subjects within 2.0 km and 607 non-exposed patients were
8.7 and 3.0 cases per 10(5) persons per year, respectively. The incidences
of meningioma among the survivors of Hiroshima in 5-year intervals since 1
975 were 5.3, 7.4, 10.1, and 14.9, respectively. The incidences of meningio
ma classified by distances from the hypocenter of 1.5-2.0 km, 1.0-1.5 km an
d less than 1.0 km were 6.3, 7.6 and 20.0, respectively. The incidences of
meningioma classified by doses to the brain of 0-0.099 Sv, 0.1-0.99 Sv and
more than 1.0 Sv were 7.7, 9.2 and 18.2, respectively. The incidence of men
ingioma among Hiroshima atomic bomb survivors has increased since 1975. The
re was a significant correlation between the incidence and the dose of radi
ation to the brain. The present findings strongly suggest that meningioma i
s one of the tumors induced by atomic bombing in Hiroshima.